{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T05:10:32Z","timestamp":1775279432561,"version":"3.50.1"},"reference-count":24,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2026]]},"DOI":"10.3960\/jslrt.25057","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T22:12:48Z","timestamp":1774908768000},"page":"45-51","source":"Crossref","is-referenced-by-count":0,"title":["CD5-positive diffuse large B-Cell lymphoma presenting with protein-losing enteropathy"],"prefix":"10.3960","volume":"66","author":[{"given":"Kenji","family":"Moriwaki","sequence":"first","affiliation":[{"name":"Department of Hematology, Rheumatology and Infectious Diseases, Kumamoto University Hospital, Kumamoto, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiro","family":"Tatetsu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Rheumatology and Infectious Diseases, Kumamoto University Hospital, Kumamoto, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Higuchi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Rheumatology and Infectious Diseases, Kumamoto University Hospital, Kumamoto, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahisa","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Hematology, Rheumatology and Infectious Diseases, Kumamoto University Hospital, Kumamoto, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayuko","family":"Naito","sequence":"additional","affiliation":[{"name":"Department of Hematology, Rheumatology and Infectious Diseases, Kumamoto University Hospital, Kumamoto, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asami","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Hematology, Rheumatology and Infectious Diseases, Kumamoto University Hospital, Kumamoto, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Shichijo","sequence":"additional","affiliation":[{"name":"Department of Hematology, Rheumatology and Infectious Diseases, Kumamoto University Hospital, Kumamoto, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Tokunaga","sequence":"additional","affiliation":[{"name":"Department of Hematology, Rheumatology and Infectious Diseases, Kumamoto University Hospital, Kumamoto, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Gushima","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kumamoto University Hospital, Kumamoto, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Shiota","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kumamoto University Hospital, Kumamoto, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Mikami","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kumamoto University Hospital, Kumamoto, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kisato","family":"Nosaka","sequence":"additional","affiliation":[{"name":"Department of Hematology, Rheumatology and Infectious Diseases, Kumamoto University Hospital, Kumamoto, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhito","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kumamoto University Hospital, Kumamoto, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kennosuke","family":"Karube","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Graduate School of Medicine, Nagoya University, Nagoya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-ichiro","family":"Yasunaga","sequence":"additional","affiliation":[{"name":"Department of Hematology, Rheumatology and Infectious Diseases, Kumamoto University Hospital, Kumamoto, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Sieniawski M, Angamuthu N, Boyd K <i>et al.<\/i> Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation. Blood. 2010; 115: 3664-3670.","DOI":"10.1182\/blood-2009-07-231324"},{"key":"2","unstructured":"2 Bautista-Quach MA, Ake CD, Chen M, Wang J. Gastrointestinal lymphomas: Morphology, immunophenotype and molecular features. J Gastrointest Oncol. 2012; 3: 209-225."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Ghimire P, Wu GY, Zhu L. Primary gastrointestinal lymphoma. World J Gastroenterol. 2011; 17: 697-707.","DOI":"10.3748\/wjg.v17.i6.697"},{"key":"4","unstructured":"4 Nakayama A, Sakai K, Fujioka Y <i>et al.<\/i> [CD5-positive diffuse large B-cell lymphoma with gastrointestinal infiltration presenting with protein-losing enteropathy]. Rinsho Ketsueki. 2022; 63: 530-535."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Elli L, Topa M, Rimondi A. Protein-losing enteropathy. Curr Opin Gastroenterol. 2020; 36: 238-244.","DOI":"10.1097\/MOG.0000000000000629"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Chen X, Wang J, Liu Y <i>et al.<\/i> Primary intestinal diffuse large B-cell lymphoma: novel insights and clinical perception. Front Oncol. 2024; 14: 1404298.","DOI":"10.3389\/fonc.2024.1404298"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Minemura T, Kikuchi S, Mihara H <i>et al.<\/i> Protein-losing Enteropathy Complicated with Primary Intestinal Follicular Lymphoma. Intern Med. 2022; 61: 2051-2055.","DOI":"10.2169\/internalmedicine.8261-21"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Naymagon L, Ward S, Naymagon S, Navada S. Severe Protein-Losing Enteropathy Due to an Indolent Splenic Lymphoma: Case Report and Review of the Literature. Clin Lymphoma Myeloma Leuk. 2019; 19: e165-e168.","DOI":"10.1016\/j.clml.2018.12.015"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Tsukamoto A, Nakamura F, Nannya Y <i>et al.<\/i> MALT lymphoma of the small bowel with protein-losing enteropathy. Int J Hematol. 2014; 99: 198-201.","DOI":"10.1007\/s12185-013-1492-8"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Chieng JH, Garrett J, Ding SL, Sullivan M. Clinical presentation and endoscopic features of primary gastric Burkitt lymphoma in childhood, presenting as a protein-losing enteropathy: a case report. J Med Case Rep. 2009; 3: 7256.","DOI":"10.4076\/1752-1947-3-7256"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Kaneko H, Yamashita M, Ohshiro M <i>et al.<\/i> Protein-losing enteropathy in a case of nodal follicular lymphoma without a gastrointestinal mucosal lesion. Intern Med. 2008; 47: 2171-2173.","DOI":"10.2169\/internalmedicine.47.1189"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Pratz KW, Dingli D, Smyrk TC, Lust JA. Intestinal lymphangiectasia with protein-losing enteropathy in Waldenstrom macroglobulinemia. Medicine (Baltimore). 2007; 86: 210-214.","DOI":"10.1097\/MD.0b013e31812e5242"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Stanek N, Bauerfeind P, Herzog G <i>et al.<\/i> Marginal Zone Lymphoma Complicated by Protein Losing Enteropathy. Case Rep Hematol. 2016; 2016: 9351408.","DOI":"10.1155\/2016\/9351408"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Hu D, Cui X, Ren W <i>et al.<\/i> A case of primary intestinal lymphangiectasia with non-Hodgkin lymphoma. BMC Gastroenterol. 2021; 21: 461.","DOI":"10.1186\/s12876-021-01997-x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Miyazaki K, Asano N, Yamada T <i>et al.<\/i> DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase II study. Haematologica. 2020; 105: 2308-2315.","DOI":"10.3324\/haematol.2019.231076"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Yamaguchi M, Seto M, Okamoto M <i>et al.<\/i> De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients. Blood. 2002; 99: 815-821.","DOI":"10.1182\/blood.V99.3.815"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Maeshima AM, Taniguchi H, Nomoto J <i>et al.<\/i> Secondary CD5+ diffuse large B-cell lymphoma not associated with transformation of chronic lymphocytic leukemia\/small lymphocytic lymphoma (Richter syndrome). Am J Clin Pathol. 2009; 131: 339-346.","DOI":"10.1309\/AJCP58FETFGLCKKW"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Maeshima AM, Omatsu M, Nomoto J <i>et al.<\/i> Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma: morphological, immunohistochemical, and FISH analyses. Cancer Sci. 2008; 99: 1760-1768.","DOI":"10.1111\/j.1349-7006.2008.00873.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Vassallo J, Bousquet M, Quelen C <i>et al.<\/i> CD5-positive diffuse large B cell lymphoma arising from a CD5-positive follicular lymphoma. J Clin Pathol. 2007; 60: 573-575.","DOI":"10.1136\/jcp.2005.032896"},{"key":"20","unstructured":"20 Koike T, Iriyama N, Nakagawa M <i>et al.<\/i> [Transformation of CD5-positive nodal marginal zone lymphoma to diffuse large B-cell lymphoma]. Rinsho Ketsueki. 2020; 61: 245-250."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Maeshima AM, Taniguchi H, Toyoda K <i>et al.<\/i> Clinicopathological features of histological transformation from extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue to diffuse large B-cell lymphoma: an analysis of 467 patients. Br J Haematol. 2016; 174: 923-931.","DOI":"10.1111\/bjh.14153"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Xia Y, Ge J, Sun Z <i>et al.<\/i> CD5-positive marginal zone lymphoma: Clinicopathological features and survival outcomes. Leuk Res. 2022; 117: 106840.","DOI":"10.1016\/j.leukres.2022.106840"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Vignes S, Bellanger J. [Primary intestinal lymphangiectasia (Waldmann\u2019s disease)]. Rev Med Interne. 2018; 39: 580-585.","DOI":"10.1016\/j.revmed.2017.07.009"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Laharie D, Degenne V, Laharie H <i>et al.<\/i> Remission of protein-losing enteropathy after nodal lymphoma treatment in a patient with primary intestinal lymphangiectasia. Eur J Gastroenterol Hepatol. 2005; 17: 1417-1419.","DOI":"10.1097\/00042737-200512000-00024"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/66\/1\/66_25057\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:31:32Z","timestamp":1775277092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/66\/1\/66_25057\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.25057","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"25057"}}